PHARMACOKINETICS OF SUBCUTANEOUS INFLIXIMAB INDUCTION AND MAINTENANCE IN MODERATE-TO-SEVERELY ACTIVE CROHN'S DISEASE PATIENTS: WEIGHT MATTERS

被引：0
|
作者：
Anjie, Suzanne I.
Mathot, Ron
Gecse, Krisztina
D'Haens, Geert
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1811
引用
收藏
页码：S824 / S825
页数：2
相关论文
共 50 条
  • [21] MAINTENANCE INFLIXIMAB DOSING AND ADMINISTRATION PATTERNS IN PATIENTS WITH CROHN'S DISEASE
    Bailey, R.
    Waters, H.
    Ernst, F. R.
    Johnson, B.
    McKenzie, R. S.
    VALUE IN HEALTH, 2010, 13 (03) : A216 - A216
  • [22] Thiopurines and their optimization during infliximab induction and maintenance: A retrospective study in Crohn's disease
    Luber, Raphael P.
    Dawson, Luke
    Munari, Stephanie
    Kariyawasam, Viraj C.
    Martin, Catherine
    Gibson, Peter R.
    Sparrow, Miles P.
    Ward, Mark G.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (04) : 990 - 998
  • [23] Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease
    Mahadevan, U
    Kane, S
    Sandborn, WJ
    Cohen, RD
    Hanson, K
    Terdiman, JP
    Binion, DG
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (06) : 733 - 738
  • [24] THE COST-EFFECTIVENESS OF USTEKINUMAB IN MODERATE TO SEVERELY ACTIVE CROHN'S DISEASE IN SWEDEN
    Hansson-Hedblom, A.
    Almond, C.
    Borgstrom, F.
    Sly, I
    Enkusson, D.
    Buchholt, Troelsgaard A.
    Karlsson, L.
    VALUE IN HEALTH, 2017, 20 (09) : A634 - A634
  • [25] Comparison of Infliximab and Infliximab/Azathioprine for Maintenance Therapy in Korean Patients with Luminal Crohn's Disease
    Won, Hyun Sun
    Park, Dong Il
    Chon, Chang Uk
    Seok, Hyo Sun
    Kim, Tae Wan
    Heo, Woon Je
    Lee, Chang Kyun
    Eun, Chang Soo
    Han, Dong Soo
    Lee, Suck-Ho
    INTESTINAL RESEARCH, 2011, 9 (03) : 189 - 195
  • [26] RAPID SYMPTOMATIC IMPROVEMENT WITH SUBCUTANEOUS INFLIXIMAB INDUCTION TREATMENT FOR PATIENTS WITH MODERATE TO SEVERE CROHN'S DISEASE: FIRST RESULTS FROM THE DIRECT-CD STUDY
    Anjie, Suzanne I.
    Jharap, Bindia
    Jansen, Jeroen M.
    Mares, Wout
    Duijvestein, Marjolijn
    Maljaars, Jeroen
    Oldenburg, Bas
    D'Haens, Geert
    Gecse, Krisztina
    GASTROENTEROLOGY, 2024, 166 (05) : S510 - S510
  • [27] Induction and Maintenance Treatment with Risankizumab Leads to Symptomatic Relief in Patients With Moderate to Severe Crohn's Disease
    Louis, Edouard
    Torres, Joana
    Lindsay, James
    Schreiber, Stefan
    Ungaro, Ryan
    Jonaitis, Laimas
    Kligys, Kristina
    Van Haaren, Stijn
    Neimark, Ezequiel
    Zambrano, Javier
    Zhang, Yafei
    D'Haens, Geert
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S496 - S497
  • [28] Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials
    Sandborn, William J.
    Colombel, Jean-Frederic
    Panes, Julian
    Castillo, Majin
    Robinson, Anne M.
    Zhou, Qian
    Yang, Mei
    Thakkar, Roopal
    JOURNAL OF CROHNS & COLITIS, 2013, 7 (12): : 958 - 967
  • [29] Population pharmacokinetics of single dose infliximab in patients with Crohn's disease.
    Fasanmade, AA
    Zhu, YW
    Wagner, C
    Pendley, C
    Davis, HM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P66 - P66
  • [30] Population Pharmacokinetics and Exposure-Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Kowalski, Ken
    Sandborn, William J.
    Feagan, Brian
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1336 - 1355
12345